Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VB-201 for hospitalized adults with moderate COVID-19
MOH_2020-10-29_009450Phase 2Completed
- Sponsor
- VBL Therapeutics
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing VB-201 plus standard of care with Standard of care (2 arms). Started Jul 2020; status: completed.
02
Drugs
VB-201
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2020-10-29_009450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-10-29_009450.